(:AMRS)

Jun 26, 2023 09:10 am ET
AMYRIS ANNOUNCES CEO TRANSITION AND GLOBAL REDUCTION IN FORCE
EMERYVILLE, Calif., June 26, 2023 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, today announced that John Melo has resigned from his role as President & Chief Executive Officer and a member of the Board of Directors, effective immediately. The Company's Board of Directors has appointed Han Kieftenbeld as Interim Chief Executive Officer. Mr. Kieftenbeld will remain as the Company's Chief Financial Officer.
Jun 05, 2023 08:36 am ET
AMYRIS INITIATES STRATEGIC TRANSFORMATION PROGRAM AND SECURES FUNDING
EMERYVILLE, Calif., June 5, 2023 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-MarketTM technology platform and clean beauty consumer brands, today announced that its Board of Directors has engaged the Business Recovery Services unit of PricewaterhouseCoopers ("PwC") and established a subcommittee of the Board (the "Restructuring Committee"), made up of three independent directors, working with Management, to execute on a transformation program to accelerate improvements
May 19, 2023 08:00 am ET
AMYRIS COMPLETES LICENSE FOR SUPPLY OF SUSTAINABLE SQUALENE
EMERYVILLE, Calif., May 19, 2023 Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, today announced that it has signed an exclusive license agreement with British specialty chemicals company Croda International Plc, ("Croda") for the supply of sustainable squalene.
May 09, 2023 04:05 pm ET
AMYRIS, INC. REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
Core revenue of $56.1 million exceeded Q1 guidance of $49.9 millionCash operating expense down 4% compared to Q1 2022 and down 24% versus Q4 2022Completed strategic partnership with Givaudan on April 3 for $200 million upfront cashEMERYVILLE, Calif., May 9, 2023 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-MarketTM technology platform and clean beauty consumer brands, today announced financial results for the first quarter ended March 31, 2023.   
May 02, 2023 08:00 am ET
AMYRIS TO HOST FIRST QUARTER 2023 FINANCIAL RESULTS CONFERENCE CALL ON MAY 9
EMERYVILLE, Calif., May 2, 2023 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, today announced that it will issue its financial results for the first quarter ended March 31, 2023, on the afternoon of Tuesday, May 9, 2023, after closing of the financial markets.
Apr 24, 2023 08:59 am ET
AMYRIS REPORTS Q1 2023 REVENUE
EMERYVILLE, Calif., April 24, 2023 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, provided an update on first quarter revenue.
Apr 05, 2023 08:00 am ET
AMYRIS CLOSES STRATEGIC TRANSACTION WITH GIVAUDAN
Leveraging Amyris' industry-leading biotechnology platform in Beauty for the development and supply of clean sustainable ingredients
Mar 15, 2023 04:11 pm ET
AMYRIS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS
Fourth quarter Consumer revenue of $52.8 million increased 64% over the prior year and was another record quarter. Core revenue of $75.8 million grew 17% over the prior yearFull year Consumer revenue of $176.9 million increased 92% and outperformed prestige beauty industry growth of 15%. Core revenue of $269.8 million grew 44% over prior yearUse of cash for operating and investing activities sequentially improved each quarter; Q4 2022 down $102 million versus Q1 2022Actions taken to simplify portfolio, streamline management structure and deliver efficienciesEMERYVILLE, Calif., March 15, 2023
Jan 30, 2023 07:00 am ET
AMYRIS LAUNCHES 4U BY TIA™ HAIRCARE LINE EXCLUSIVELY AT WALMART
EMERYVILLE, Calif., Jan. 30, 2023 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced the launch of 4U by TiaTM, a new haircare line available exclusively at Walmart.
Jan 04, 2023 07:00 am ET
AMYRIS TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTH CARE CONFERENCE
EMERYVILLE, Calif., Jan. 4, 2023 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced that management will present at the 41st Annual J.P. Morgan Health Care Conference on Wednesday, January 11, 2023, at 11:15 am PT (2:15 pm ET) in San Francisco.
Dec 29, 2022 07:00 am ET
AMYRIS ANNOUNCES $50 MILLION REGISTERED DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENT
EMERYVILLE, Calif., Dec. 29, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that it has entered into a definitive purchase agreement for the purchase and sale of 20,000,000 shares of the Company's common stock and warrants to purchase up to an aggregate of 15,000,000 shares of common stock in a registered direct offering.  Each share of common stock is being sold together with a warrant to purchase 0.75 of a share of commo
Dec 27, 2022 07:00 am ET
AMYRIS SUCCESSFULLY ADVANCES STRATEGIC TRANSACTION
EMERYVILLE, Calif., Dec. 27, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-MarketTM technology platform today announced that it has completed the negotiation of key financial and business terms of the previously communicated strategic transaction for the exclusive rights to supply two of Amyris' ingredients.
Dec 19, 2022 10:02 am ET
Thinking about buying stock in Mullen Automotive, Soleno Therapeutics, Agrify, AMC Entertainment, or Amyris?
NEW YORK, Dec. 19, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MULN, SLNO, AGFY, AMC, and AMRS.
Nov 30, 2022 07:00 am ET
AMYRIS CONSUMER BRANDS DELIVER 80% CYBER MONDAY LIKE-FOR-LIKE GROWTH
EMERYVILLE, Calif., Nov. 30, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-MarketTM technology platform today announced continued year-over-year growth on Cyber Monday, November 28, 2022.
Nov 28, 2022 07:56 am ET
AMYRIS CONSUMER BRANDS DELIVER RECORD BLACK FRIDAY WEEK SALES
EMERYVILLE, Calif., Nov. 28, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced record consumer sales performance during this year's Black Friday sales week from Friday, November 18 through Saturday, November 26.
Nov 08, 2022 03:05 pm ET
AMYRIS, INC. REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
Sixth consecutive quarter of record consumer revenue – Consumer revenue of $46.6 million increased 98% compared to Q3 2021Record core revenue of $71.1 million grew 49% compared to the prior year quarter"Fit to Win" revenue, cost and cash actions deliver $10 million in Q3$180 million of new funding closed - strategic transaction on track to self-fund growthEMERYVILLE, Calif., Nov. 8, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform and clean
Nov 01, 2022 08:00 am ET
AMYRIS TO HOST THIRD QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL ON NOVEMBER 8
EMERYVILLE, Calif., Nov. 1, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-MarketTM technology platform and clean beauty consumer brands, today announced that it will issue its financial results for the third quarter ended September 30, 2022, on the afternoon of Tuesday, November 8, 2022, after closing of the financial markets.
Oct 25, 2022 08:00 am ET
Amyris and World Wildlife Fund Announce Partnership to Protect Biodiversity
EMERYVILLE, Calif., Oct. 25, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, today announced a partnership with World Wildlife Fund (WWF), one of the world's leading conservation organizations, to support WWF's efforts to improve ocean health and reduce the impact of fishing on shark populations.
Oct 24, 2022 08:00 am ET
AMYRIS SUCCESSFULLY LAUNCHES TWO NEW CONSUMER BRANDS
EMERYVILLE, Calif., Oct. 24, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, announces the launch of two new brands under its growing consumer portfolio: Stripes™, a (peri)menopausal wellness brand founded in partnership with actress, entrepreneur and activist, Naomi Watts, and EcoFabulous™, a clean, sustainable beauty brand designed for Gen-Z consumers, offering high performing color cosmetics and skin-care products at an accessible price
Oct 17, 2022 08:30 am ET
Thinking about buying stock in Archaea Energy, Agrify, Milestone Pharmaceuticals, Revlon, or Amyris?
NEW YORK, Oct. 17, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LFG, AGFY, MIST, REV, and AMRS.
Oct 11, 2022 08:43 am ET
Amyris Brands Expanding in UK and Europe. Executing on continued accelerated growth and lower costs
EMERYVILLE, Calif., Oct. 11, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, today announced that three of its consumer brands will be included in Sephora's launch in the United Kingdom (UK). 
Sep 30, 2022 09:35 am ET
Thinking about buying stock in F45 Training, Edesa Biotech, Amyris, Carnival Corp, or Intercept Pharmaceuticals?
NEW YORK, Sept. 30, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for FXLV, EDSA, AMRS, CCL, and ICPT.
Sep 14, 2022 10:46 am ET
Thinking about buying stock in Cisco Systems, Sonnet BioTherapeutics, Nikola Corp, Baudax Bio, or Amyris?
NEW YORK, Sept. 14, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CSCO, SONN, NKLA, BXRX, and AMRS.
Sep 07, 2022 08:00 am ET
AMYRIS TO PARTICIPATE AT SEPTEMBER INVESTOR CONFERENCES
EMERYVILLE, Calif., Sept. 7, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, today announced that management will participate in fireside chats moderated by equity research analysts, and provide updates, at two upcoming investor conferences:
Aug 31, 2022 04:06 pm ET
AMYRIS PUBLISHES SECOND ANNUAL ESG REPORT
EMERYVILLE, Calif., Aug. 31, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-MarketTM technology platform and clean beauty consumer brands, published today its 2021 Environmental, Social, and Governance ("ESG") report, highlighting the company's commitment to leading the worlds transition to clean, sustainable chemistry.  
Aug 09, 2022 08:00 am ET
AMYRIS, INC. REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
Record consumer revenue of $43 million increased 108% compared to Q2 2021Ingredients sold out in first half with $15 million backlog to be supplied in H2Cost actions and price increases to deliver $50 million of EBITDA improvements in H2$700 million non-equity funding and earnout provides liquidity to sustained profitabilityEMERYVILLE, Calif., Aug. 9, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-MarketTM technology platform and clean beauty consumer brands, today a
Aug 03, 2022 08:00 am ET
AMYRIS TO PARTICIPATE AT THE UBS GENOMICS 2.0 AND MEDTECH INNOVATIONS SUMMIT
EMERYVILLE, Calif., Aug. 3, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that management will participate in a fireside chat at the UBS Genomics 2.0 and MedTech Innovations Summit on Wednesday, August 10, 2022, at 3:00 pm PT/ 6:00 pm ET in Dana Point, CA. Speaking on behalf of Amyris will be Sunil Chandran, Chief Science Officer and Head of Research and Development.
Jul 28, 2022 08:00 am ET
AMYRIS TO HOST SECOND QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL ON AUGUST 9
EMERYVILLE, Calif., July 28, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that it will issue its financial results for the second quarter ended June 30, 2022, on the morning of Tuesday, August 9, 2022, prior to the opening of the financial markets.
Jun 27, 2022 08:00 am ET
EATV, the World's First Plant-based Innovation ETF, Makes History at The New York Stock Exchange (NYSE: EATV)
VegTech™ Invest, Advisor to EATV, the VegTech™ Plant-based Innovation & Climate ETF,  throws historic party at The New York Stock Exchange celebrating the EATV listing and world's first Plant-based Innovation ETF, (NYSE: EATV).
Jun 23, 2022 08:00 am ET
AMYRIS BARRA BONITA FERMENTATION PLANT BEGINS INDUSTRIAL PRODUCTION
EMERYVILLE, Calif., June 23, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced that it has successfully started fermentation at its new precision fermentation plant in Barra Bonita, Brazil.
Jun 07, 2022 08:00 am ET
AMYRIS TO PARTICIPATE AT THE OPPENHEIMER 22nd ANNUAL CONSUMER CONFERENCE
EMERYVILLE, Calif., June 7, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that management will participate in a virtual fireside chat at the Oppenheimer 22nd Annual Consumer Conference on Tuesday, June 14, 2022, at 11:15 am ET.
May 23, 2022 05:36 pm ET
AMYRIS PARTICIPATES IN INVESTOR CONFERENCES ON MAY 23, 24 AND 25, 2022
EMERYVILLE, Calif., May 23, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that management is participating in fireside chats at the following investor conferences this week:
May 23, 2022 08:00 am ET
AMYRIS TO PARTICIPATE AT MAY INVESTOR CONFERENCES
EMERYVILLE, Calif., May 23, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-MarketTM technology platform, today announced that management will participate in fireside chats at the following upcoming investor conferences. 
May 11, 2022 10:50 am ET
Thinking about buying stock in Exicure, Vroom, Redbox, Amyris, or Plug Power?
NEW YORK, May 11, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for XCUR, VRM, RDBX, AMRS, and PLUG.
May 10, 2022 08:00 am ET
AMYRIS, INC. REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
Record consumer revenue of $34.6 million increased 121% compared to Q1 2021Barra Bonita commissioning on track to commence ingredients production in Q2EMERYVILLE, Calif., May 10, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-MarketTM technology platform, today announced financial results for the first quarter ended March 31, 2022.
May 03, 2022 08:00 am ET
AMYRIS TO HOST FIRST QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL ON MAY 10
EMERYVILLE, Calif., May 3, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that it will issue its financial results for the first quarter ended March 31, 2022, on the morning of Tuesday, May 10, 2022, prior to the opening of the financial markets.
Apr 14, 2022 08:00 am ET
AMYRIS HOSTS SUCCESSFUL INVESTOR EVENT
EMERYVILLE, Calif., April 14, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, successfully hosted an in-person investor event following the Company's Nasdaq Opening Bell Ringing Ceremony. The investor event, which took place on Monday, April 11, 2022, included a presentation, a video update on the Company's precision fermentation plant in Barra Bonita, Brazil, and a moderated Consumer-oriented panel discussion.
Apr 11, 2022 08:00 am ET
AMYRIS STARTS COMMISSIONING OF INDUSTRY LEADING FERMENTATION PLANT
EMERYVILLE, Calif., April 11, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced that it has started the commissioning of its new fermentation plant in Barra Bonita, Brazil.
Mar 29, 2022 08:00 am ET
VegTech™ Invest Launches the VegTech™ Plant-based Innovation & Alternative Proteins Index
Calculated and Distributed by Morningstar Indexes, the Index Defines and Leads a New Global Investment Category in Capital Markets
Mar 17, 2022 08:00 am ET
AMYRIS TO PARTICIPATE IN THE JEFFERIES VIRTUAL SYNTHETIC BIOLOGY WEEK
EMERYVILLE, Calif., March 17, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced that management will participate in a fireside chat at the Jefferies Virtual Synthetic Biology Week on Wednesday, March 23, 2022, at 2:00 pm ET.
Mar 11, 2022 07:00 am ET
AMYRIS CLOSES ACQUISITION OF MENOLABS
EMERYVILLE, Calif., March 11, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced that it has closed the acquisition of the assets of MenoLabs, LLC, a company founded by women to treat menopause symptoms, drive research for women's health and improve society's understanding of menopause.
Mar 01, 2022 07:00 am ET
AMYRIS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS
EMERYVILLE, Calif., March 1, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-MarketTM technology platform, today announced financial results for its fourth quarter and full year ended December 31, 2021.
Feb 28, 2022 07:00 am ET
AMYRIS TO PRESENT AT THE 42nd ANNUAL COWEN HEALTH CARE CONFERENCE
EMERYVILLE, Calif., Feb. 28, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced that management will participate in a fireside chat at the 42nd Annual Cowen Health Care Conference on Monday, March 7, 2022, at 1:30 pm ET.
Feb 22, 2022 07:00 am ET
AMYRIS TO HOST FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS CONFERENCE CALL ON MARCH 1
EMERYVILLE, Calif., Feb. 22, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced that it will issue its financial results for the fourth quarter and full year ended December 31, 2021, on the morning of Tuesday, March 1, 2022, prior to the opening of the financial markets.
Feb 09, 2022 07:00 am ET
AMYRIS CLOSES ECOFABULOUS TRANSACTION, AND COMMENCES PRODUCTION OF CONSUMER PRODUCTS IN RENO, NEVADA PLANT
EMERYVILLE, Calif., Feb. 9, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ operating platform today announced that it has closed the acquisition of EcoFabulous, a Gen Z-focused clean beauty consumer brand. Amyris also announced the start of production of a range of consumer products at the Reno, Nevada facility ahead of its mid-year schedule.
Jan 27, 2022 07:00 am ET
AMYRIS ANNOUNCES APPOINTMENT OF ANA DUTRA TO BOARD OF DIRECTORS
EMERYVILLE, Calif., Jan. 27, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-MarketTM operating platform, today announced the appointment of Ms. Ana Dutra as its newest independent member of the Amyris Board of Directors, effective January 21, 2022.
Jan 05, 2022 07:00 am ET
AMYRIS TO PRESENT AT THE 40th ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
EMERYVILLE, Calif., Jan. 5, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ operating platform, today announced that management will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022, at 11:15 am ET.
Jan 03, 2022 07:00 am ET
AMYRIS AND IMMUNITYBIO COMPLETE JOINT VENTURE FOR NEXT GENERATION COVID-19 RNA VACCINE
EMERYVILLE, Calif. and CULVER CITY, Calif., Jan. 3, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-Market™ operating platform, and ImmunityBio (Nasdaq: IBRX), a clinical-stage immunotherapy company, today announced the completion of a previously announced joint venture agreement to accelerate the commercialization of a leading next-generation COVID-19 vaccine.
Dec 23, 2021 06:00 am ET
AMYRIS AND MINERVA FOODS COMPLETE JOINT VENTURE AND LICENSE AGREEMENTS TO SCALE LOW CARBON PROTEIN PRODUCTION PLATFORM
EMERYVILLE, Calif., Dec. 23, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-MarketTM operating platform, today announced the completion of a previously announced joint venture agreement with MF 92 VENTURES LLC ("Minerva"), a Minerva Foods subsidiary, to develop molecules for the sustainable production and distribution of animal protein ("the Joint Venture").
Dec 10, 2021 05:15 pm ET
Federman & Sherwood Announces Certification of Securities Class Action Lawsuit Against Amyris, Inc.
Federman & Sherwood announces that on December 8, 2021, a class action lawsuit was certified in the United States District Court for the Northern District of California against Amyris, Inc. (NASDAQ: AMRS), its CEO John Melo, and its former CFO Kathleen Valiasek. The court certified a Class of investors who purchased shares of Amyris, Inc. common stock during the period from March 15, 2018 through March 19, 2019 (the “Class Period”) and who were damaged thereby.
Nov 30, 2021 07:00 am ET
Amyris Consumer Brands Deliver Record Black Friday Week
EMERYVILLE, Calif., Nov. 30, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-Market™ operating platform, today announced strong year-over-year consumer sales performance during this year's Black Friday sales week.
Nov 23, 2021 03:05 pm ET
Amyris To Present At The Evercore ISI 4th Annual HealthCONx Conference On December 1, 2021
EMERYVILLE, Calif., Nov. 23, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-Market™ operating platform, today announced that management will participate in a fireside chat at the Evercore ISI 4th Annual HealthCONx Conference on Wednesday, December 1st at 3:30 pm ET.
Nov 18, 2021 08:12 am ET
Amyris To Host Call Regarding Recent Financing Activity
EMERYVILLE, Calif., Nov. 18, 2021 /PRNewswire/ -- Amyris, Inc., (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-Market™ operating platform, today announced that it will host a conference call and live webcast to discuss its recent financing activity on Monday, November 22, 2021 beginning at 6:00 a.m. Pacific Time (9:00 a.m. Eastern Time), John Melo, President and Chief Executive Officer, and Han Kieftenbeld, Chief Financial Officer, will discuss the Company's recent strategic financing.
Nov 15, 2021 04:31 pm ET
Amyris Closes Upsized Offering Of $690.0 Million Of 1.50% Convertible Senior Notes Due 2026
EMERYVILLE, Calif., Nov. 15, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-MarketTM operating platform, announced that it has closed its offering of 1.50% convertible senior notes due 2026 (the "notes"), for gross proceeds of $690.0 million.  The proceeds include the full exercise of the $90.0 million option granted by Amyris to the initial purchasers of the notes. The notes were offered and sold in a private placement to persons reasonably believed to be qualified institutional
Nov 10, 2021 07:00 am ET
Amyris Prices $600.0 Million Of 1.50% Convertible Senior Notes Due 2026
EMERYVILLE, Calif., Nov. 10, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-MarketTM operating platform, today announced that it has priced $600.0 million aggregate principal amount of 1.50% convertible senior notes due 2026 (the "notes"). The size of the offering was increased from the previously announced $400.0 million in aggregate principal amount. The notes are to be offered and sold in a private placement to persons reasonably believed to be qualified institut
Nov 08, 2021 03:35 pm ET
Amyris To Offer $400.0 Million Of Convertible Senior Notes Due 2026
EMERYVILLE, Calif., Nov. 8, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-Market™ operating platform, today announced that it proposes to offer $400.0 million aggregate principal amount of convertible senior notes due 2026 (the "notes"), subject to market conditions and other factors. The notes are to be offered and sold in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as
Nov 08, 2021 03:11 pm ET
Amyris, Inc. Reports Third Quarter 2021 Financial Results
EMERYVILLE, Calif., Nov. 8, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-MarketTM operating platform, today announced financial results for its third quarter ended September 30, 2021.
Nov 08, 2021 07:00 am ET
Amyris Announces JV Partnership With ImmunityBio For Next Generation COVID-19 RNA Vaccine
EMERYVILLE, Calif., Nov. 8, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-MarketTM operating platform, today announced it has entered into a 50:50 joint venture arrangement with ImmunityBio, Inc. (Nasdaq: IBRX), a clinical-stage immunotherapy company, to accelerate the commercialization of a leading next-generation COVID-19 vaccine.
Oct 28, 2021 08:00 am ET
Amyris to Host Third Quarter 2021 Financial Results Conference Call on November 8
EMERYVILLE, Calif., Oct. 28, 2021 /PRNewswire/ -- Amyris, Inc., (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it will issue its financial results for the third quarter ended September 30, 2021 after the close of the financial markets on Monday, November 8, 2021.
Oct 05, 2021 08:00 am ET
Amyris Partners with Inscripta to Enhance Development of Sustainable Ingredients Using the Onyx™ Genome Engineering Platform
EMERYVILLE, Calif. and BOULDER, Colo., Oct. 5, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that Amyris has licensed the Onyx genome engineering platform from Inscripta, a leading gene editing technology company. Amyris and Inscripta will also explore joint research and development opportunities to expand the Onyx platform functionality.
Oct 01, 2021 08:00 am ET
Amyris Hosts Successful Fourth Webinar In Its Virtual Investor Mini-Series
EMERYVILLE, Calif., Oct. 1, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, successfully hosted the fourth webinar in its virtual investor mini-series. The investor mini-series entitled "Lab-to-Market, Delivering Disruptive Health and Beauty Products" was conducted via live webcast and teleconference on Tuesday, September 28, 2021.
Sep 22, 2021 08:00 am ET
Amyris To Host Fourth Webinar In Its Virtual Investor Mini-Series
EMERYVILLE, Calif., Sept. 22, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in the Clean Health, Beauty and Wellness markets, today announced that it will host its fourth virtual investor webinar on Tuesday, September 28, 2021.
Sep 08, 2021 08:00 am ET
Amyris to Present at Two September Investor Conferences
EMERYVILLE, Calif., Sept. 8, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that management  will present at two upcoming investor conferences and provide a business update.
Sep 07, 2021 08:00 am ET
Amyris Closes Acquisition Of Beauty Labs Combining Synthetic Biology Leadership With Digital Innovation
EMERYVILLE, Calif., Sept. 7, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that, on August 31, it closed the acquisition of Beauty Labs International Ltd. ("Beauty Labs"), a leader in AI technology that provides breakthrough connected consumer experiences to the beauty and wellness community.  
Aug 26, 2021 08:30 am ET
Amyris And Jonathan Van Ness Launch JVN Hair A Transformation In Clean Hair Products
EMERYVILLE, Calif., Aug. 26, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the launch of JVN™, a clean hair products brand. Today's launch is the third of three highly anticipated brand launches Amyris is introducing to the market this summer.
Aug 24, 2021 08:00 am ET
Amyris Closes Acquisitions Of OLIKA Inc. And MG Empower
EMERYVILLE, Calif., Aug. 24, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it closed the acquisitions of OLIKA, Inc. (OLIKA), an award-winning clean consumer brand, and MG Empower Ltd., a leading global influencer marketing agency on August 11.  
Aug 23, 2021 08:00 am ET
Amyris And Rosie Huntington-Whiteley's Rose Inc. Brand Launches Its First Collection Of Beauty Products
EMERYVILLE, Calif., Aug. 23, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the launch of Rose Inc., a clean color cosmetics brand. Today's launch is the second of three highly anticipated brand launches Amyris is introducing to the market this summer.
Aug 20, 2021 09:31 am ET
Thinking about buying stock in 360 DigiTech, CohBar, Buckle, Amyris, or Senseonics?
NEW YORK, Aug. 20, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for QFIN, CWBR, BKE, AMRS, and SENS.
Aug 20, 2021 08:00 am ET
Amyris Achieves Promising In-Vivo Results For Intranasal Delivery Of RNA/NLC Vaccine
EMERYVILLE, Calif., Aug. 20, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced promising in-vivo results in a study of its licensed RNA vaccine through intranasal delivery, developed in collaboration with the Infectious Disease Research Institute (IDRI).
Aug 19, 2021 08:00 am ET
Amyris Launches Terasana Clinical Clean Skincare Brand
EMERYVILLE, Calif., Aug. 19, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the launch of Terasana™ Clinical, a clean skincare brand. Today's launch represents the first of three highly anticipated brand launches Amyris will launch this summer.
Aug 16, 2021 08:00 am ET
Amyris Launches Next Virtual Investor Mini-Series
EMERYVILLE, Calif., Aug. 16, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, announced today that it will be hosting an encore to its first three-part virtual investor mini-series themed "Delivering on the Promise of Synthetic Biology".
Aug 05, 2021 08:00 am ET
Amyris, Inc. Reports Second Quarter 2021 Financial Results
EMERYVILLE, Calif., Aug. 5, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced financial results for its second quarter ended June 30, 2021.
Aug 03, 2021 08:00 am ET
Amyris to Present at the Oppenheimer 24th Annual Technology, Internet & Communications Conference on August 10, 2021
EMERYVILLE, Calif., Aug. 3, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that John Melo, President and Chief Executive Officer, will present at the Oppenheimer 24th Annual Technology, Internet & Communications Conference on Tuesday, August 10th at 9:55 am ET.
Jul 22, 2021 08:00 am ET
Amyris Partners With Naomi Watts To Launch Science-Backed Wellness Brand Focused On Menopause
EMERYVILLE, Calif., July 22, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced a partnership with Naomi Watts to create a new consumer brand to provide science-backed, menopause wellness personal care products. Ms. Watts, actress, mom and co-founder of ONDA Beauty, has a personal commitment to clean skincare, wellness and destigmatizing menopause.
Jul 21, 2021 08:00 am ET
Amyris To Host Second Quarter 2021 Financial Results Conference Call On August 5
EMERYVILLE, Calif., July 21, 2021 /PRNewswire/ --  Amyris, Inc., (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it will issue its financial results for the second quarter ended June 30, 2021 on the morning of Thursday, August 5, 2021, prior to the opening of the financial markets.
Jul 13, 2021 08:00 am ET
Amyris Publishes Environmental, Social and Governance (ESG) Report and Sets ESG Impact Goals
EMERYVILLE, Calif., July 13, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today released its first Environmental, Social and Governance (ESG) report, underscoring the company's founding commitment to making people and the planet healthier.
Jul 01, 2021 08:00 am ET
Amyris Completes First Major License For Leading RNA Vaccine Advancing Technology To Human Trials
EMERYVILLE, Calif., July 1, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it has signed an exclusive license with Nant Africa, LLC relating to the development and use of the RNA COVID vaccine Amyris developed in coordination with the Infectious Disease Research Institute (IDRI).
Jun 17, 2021 08:00 am ET
Amyris Partners with UNCF and 10,000 Degrees to Establish Scholarships
EMERYVILLE, Calif., June 17, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced partnerships with the UNCF (United Negro College Fund) and 10,000 Degrees® to establish a $180,000 scholarship fund to support Black and African American students pursuing higher education across STEM (science, technology, engineering, and math), business, and marketing studies.
Jun 16, 2021 08:03 am ET
Amyris to Present at the Jefferies Virtual Consumer Conference on June 23, 2021
EMERYVILLE, Calif., June 16, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced that John Melo, President and Chief Executive Officer, will participate at the Jefferies Virtual Consumer Conference on Wednesday, June 23rd at 3:15 pm ET.
Jun 15, 2021 08:00 am ET
Amyris To Acquire OLIKA Consumer Brand, Expanding Family Of Clean Consumer Brands And Accelerating Growth
EMERYVILLE, Calif., June 15, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it has executed a binding term sheet for the acquisition of award-winning, clean wellness company OLIKA Inc. (OLIKA). The acquisition furthers Amyris's growth and market leadership in clean health and beauty, and complements Amyris's family of consumer brands.
May 03, 2021 03:36 pm ET
Amyris and Ingredion Partner to Manufacture and Market Sugar Reduction and Fermentation-Based Food Ingredients
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it has signed an...
Mar 12, 2021 10:50 pm ET
AMYRIS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Amyris, Inc. - AMRS
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Amyris, Inc. (NasdaqGS: AMRS).
Feb 25, 2021 07:00 am ET
Amyris Announces Participation In Upcoming Investor Conferences
EMERYVILLE, Calif., Feb. 25, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced that members of its management team will participate in two upcoming investor conferences:
Feb 24, 2021 07:00 am ET
Amyris Announces Launch of Pipette® Clean Baby Care Brand in Target Retail Stores Across North America
EMERYVILLE, Calif., Feb. 24, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that its Pipette® clean baby care brand will expand its brick and mortar retail presence in more than 600 Target stores across North America beginning in March 2021.
Feb 22, 2021 07:00 am ET
Amyris Announces Positive Pre-Clinical Results For COVID-19 RNA Vaccine Platform With Advantaged Manufacturing, Storage And Distribution Characteristics
EMERYVILLE, Calif., Feb. 22, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced highly promising preliminary data in a pre-clinical study of its ribonucleic acid (RNA) COVID-19 vaccine platform as well as the potential to address current manufacturing, supply scale-up and refrigerated storage and distribution challenges.
Feb 17, 2021 07:00 am ET
Amyris To Host Fourth Quarter And Full Year 2020 Financial Results Conference Call On March 2
EMERYVILLE, Calif., Feb. 17, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2020 on Tuesday, March 2, 2021, prior to the opening of the financial markets. The company will hold a conference call and live audio webcast at 6:00 am Pacific Time (9:00 a.m. Eastern Time).
Feb 10, 2021 07:00 am ET
Amyris Hosts Successful Second Session Of Its Virtual Investor Mini-Series
EMERYVILLE, Calif., Feb. 10, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, successfully hosted the second webinar in its virtual investor mini-series themed "Delivering on the Promise of Synthetic Biology."
Feb 03, 2021 07:00 am ET
Amyris to Host Second Webinar in its Virtual Investor Mini-Series
EMERYVILLE, Calif., Feb. 3, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it will host the second webinar in its virtual investor mini-series themed "Delivering on the Promise of Synthetic Biology".
Feb 02, 2021 07:00 am ET
Amyris Announces Breakthrough Clinical Results For Its Clean Formulation Acne Treatment
EMERYVILLE, Calif., Feb. 2, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced breakthrough results in an early clinical study of Amyris's clean topical formulation of fermentation-based ingredients for the treatment of acne.
Jan 22, 2021 10:50 pm ET
AMYRIS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Amyris, Inc. - AMRS
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Amyris, Inc. (NasdaqGS: AMRS).
Jan 22, 2021 07:00 am ET
Amyris Acquiring Terasana Brand To Offer Clean Cannabinoid Consumer Products
EMERYVILLE, Calif., Jan. 22, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it will expand its portfolio of consumer brands by launching a new range of Terasana branded clean beauty products focused on sustainably sourced natural cannabinoids.
Jan 15, 2021 07:00 am ET
Amyris Ranked Among World's Top Social And Environmental Impact Companies By Real Leaders®️
EMERYVILLE, Calif., Jan. 15, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced it has been selected as one of the top global organizations making a positive social or environmental impact. The Real Leaders 2021 Impact Awards ranked Amyris #23 among 150 recognized companies. A special ceremony to honor the winners will be held on January 27, 2021.
Jan 11, 2021 07:00 am ET
Amyris Creates Partnership With Jonathan Van Ness To Launch Leading Clean Haircare Brand
EMERYVILLE, Calif., Jan. 11, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it will be launching a new clean haircare brand through a partnership with Jonathan Van Ness, American hairdresser, television personality, podcast host, actor and author.
Jan 04, 2021 07:00 am ET
Amyris To Launch Its Biossance TM Clean Beauty Brand In China Through Partnership With Superordinary
EMERYVILLE, Calif., Jan. 4, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it will be launching its BiossanceTM Clean Beauty skincare brand into the Greater China market through a partnership with SuperOrdinary Group.
Dec 31, 2020 08:31 am ET
Thinking about buying stock in Amyris, Nio, Plug Power, TOP Ships, or Advanced Micro Devices?
NEW YORK, Dec. 31, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMRS, NIO, PLUG, TOPS, and AMD.
Dec 28, 2020 07:00 am ET
Amyris Announces Bonsucro Certification Sustainable Sugarcane Production For Clean Ingredients
EMERYVILLE, Calif., Dec. 28, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it has received Bonsucro Chain of Custody Certification.
Dec 21, 2020 08:30 am ET
SHAREHOLDER ALERT: Amyris, Inc. (NASDAQ: AMRS) Officers and Directors Under Investigation for Possible Breaches of Fiduciary Duty
SAN FRANCISCO, Dec. 21, 2020 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP is investigating potential derivative claims on behalf of shareholders of Amyris, Inc. (NASDAQ: AMRS) related to the company's overstatements regarding future royalty payments on its financial statements and false or misleading statements concerning material weaknesses in the company's internal controls.
Dec 21, 2020 07:00 am ET
Amyris Closes $50 Million Strategic Transaction
EMERYVILLE, Calif., Dec. 21, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, announced today the closing of a strategic transaction with DSM Nutritional Products Ltd, the world's leading supplier of vitamins, carotenoids and other fine chemicals to the feed, food, pharmaceutical and personal care industries.
Dec 18, 2020 07:30 am ET
Thinking about buying stock in CNS Pharmaceuticals, DermTech, Ampio Pharmaceuticals, Surface Oncology, or Amyris?
NEW YORK, Dec. 18, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CNSP, DMTK, AMPE, SURF, and AMRS.
Dec 16, 2020 07:00 am ET
Amyris Hosts Successful First Session Of Its Virtual Investor Mini-Series
EMERYVILLE, Calif., Dec. 16, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, successfully hosted the first session of its virtual investor mini-series themed "Delivering on the Promise of Synthetic Biology."
Dec 08, 2020 08:00 am ET
Purecane, the Revolutionary Sweetener Derived from Sugarcane, Wins 2020 Popular Science Best of What's New Award
EMERYVILLE, Calif., Dec. 8, 2020 /PRNewswire/ -- PurecaneTM a pioneering clean sweetener from Amyris, Inc. (NASDAQ: AMRS), a global science and technology leader of pure, sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, announces it is a recipient of a 2020 Popular Science "Best of What's New Award" in the Engineering category. Purecane sweeteners are naturally derived from sugarcane and offer all of the great taste of sugar, without any of the calories or bitter aftertaste.
Dec 03, 2020 07:00 am ET
Amyris Launches Virtual Investor Mini-Series
EMERYVILLE, Calif., Dec. 3, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, announced today that it will be launching a virtual investor mini-series themed "Delivering on the Promise of Synthetic Biology".
Nov 30, 2020 07:00 am ET
Amyris Delivers Record Black Friday Sales
EMERYVILLE, Calif., Nov. 30, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, announced today record sales revenue from its consumer brands during this year's Black Friday sales event.
Nov 23, 2020 07:00 am ET
Amyris To Present at Evercore ISI's 3rd Annual HealthCONx Conference on December 3, 2020
EMERYVILLE, Calif., Nov. 23, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that management will present at Evercore ISI's 3rd Annual HealthCONx Conference on Thursday, December 3rd at 2:40 p.m. ET.
Nov 05, 2020 07:00 am ET
Amyris, Inc. Reports Third Quarter 2020 Financial Results
EMERYVILLE, Calif., Nov. 5, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Sustainable Health and Clean Beauty markets through its consumer brands and a top supplier of sustainably sourced natural ingredients, today announced financial results for its third quarter ended September 30, 2020.
Oct 30, 2020 08:00 am ET
Amyris And Rosie Huntington-Whiteley Announce Creation Of New Clean Beauty Brand And Business Partnership
EMERYVILLE, Calif., Oct. 30, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, and Rosie Huntington-Whiteley, model turned business woman and founder of beauty commerce destination, Rose Inc., today announced the formation of a new company, Clean Beauty Collaborative, Inc.
Oct 26, 2020 11:00 am ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors
Law Offices of Howard G. Smith announces an investigation of potential claims against the board of directors of Amyris, Inc. (“Amyris” or the “Company) (NASDAQ: AMRS) concerning whether the board breached its fiduciary duties to shareholders.
Oct 23, 2020 07:06 pm ET
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announces that it has commenced an investigation of potential claims against the board of directors of Amyris, Inc. (“Amyris” or the “Company”) (NASDAQ:
Oct 23, 2020 08:00 am ET
Amyris To Host Third Quarter 2020 Financial Results Conference Call On November 5
EMERYVILLE, Calif., Oct. 23, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it will issue its financial results for the fiscal 2020 third quarter ended September 30, 2020 on Thursday, November 5, 2020. The company plans to hold a conference call and live audio webcast for analysts and investors at 6:00 am Pacific Time (9:00 a.m. Eastern Time).
Oct 22, 2020 08:00 am ET
Amyris and The Infectious Disease Research Institute Enter into Exclusive License for Novel RNA Vaccine Platform, Beginning with COVID-19 Vaccine
EMERYVILLE, Calif., Oct. 22, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced the signing of a Collaboration Agreement and License Agreement with the Infectious Disease Research Institute (IDRI) to advance a novel ribonucleic acid (RNA) vaccine platform, including accelerating the development of a COVID-19 vaccine.
Oct 20, 2020 09:30 am ET
Amyris and Arzeda Enter into Development Collaboration Agreement
SEATTLE, Oct. 20, 2020 /PRNewswire/ -- Arzeda, the Protein Design Company™, today announced that the company has entered into a joint development agreement with Amyris that leverages the complementary nature of the two companies' technology platforms to accelerate the development and commercialization of high value ingredients. This marks the second joint project between the parties. Amyris and Arzeda collaborated successfully on a Defense Advanced Research Projects Agency (DARPA) Technology Investment Agreement (TIA) during the period of 2015 – 2019.
Oct 08, 2020 09:00 am ET
The Law Offices of Frank R. Cruz Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors
The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Amyris, Inc (“Amyris” or the “Company”) (NASDAQ: AMRS) concerning whether the board breached its fiduciary duties to shareholders.
Sep 10, 2020 03:41 pm ET
LAVVAN, Inc. Files $881 Million Federal Lawsuit Against Amyris, Inc. For Patent Infringement and Trade Secret Misappropriation
NEW YORK, Sept. 10, 2020 /CNW/ -- LAVVAN, Inc. ("LAVVAN") today announced that it has filed an $881 million lawsuit against biotechnology company Amyris, Inc. ("Amyris") (Nasdaq: AMRS) relating to Amyris's use of intellectual property licensed exclusively to LAVVAN, as well as the misappropriation of LAVVAN's trade secrets. The lawsuit was filed in the United States District Court for the Southern District of New York, docket number 20-cv-7386.
Sep 01, 2020 08:30 am ET
Amyris Scales First Fermentation-Based Cannabinoid
EMERYVILLE, Calif., Sept. 1, 2020 /CNW/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it has successfully scaled up the commercial production of Cannabigerol (CBG) leveraging its industrial fermentation process capability.
Aug 06, 2020 08:30 am ET
Amyris, Inc. Reports Second Quarter 2020 Results
EMERYVILLE, Calif., Aug. 6, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced financial results for its second quarter ended June 30, 2020.
Jul 29, 2020 05:02 pm ET
Rigrodsky & Long, P.A. Files Class Action Suit Against Amyris, Inc.
Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of Delaware on behalf of holders of Amyris, Inc. (“Amyris” or the “Company”) (NASDAQ GS: AMRS) common stock (the...
Jul 29, 2020 12:25 pm ET
INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of Amyris, Inc. - AMRS
NEW YORK, July 29, 2020 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Amyris, Inc. ("Amyris" or the "Company") (Nasdaq: AMRS) relating to the Company's June 1 and June 4, 2020 financing transactions, which permit Foris Ventures, LLC to obtain Amyris common stock. Under the terms of the transaction, Amyris shareholders would receive $3.00 for each share of Amyris common stock owned.
Jul 28, 2020 09:07 pm ET
SHAREHOLDER ALERT: WeissLaw LLP Investigates Amyris, Inc.
NEW YORK, July 28, 2020 /PRNewswire/ --
Jul 27, 2020 08:30 am ET
Amyris and The Infectious Disease Research Institute Partner to Advance Novel RNA Vaccine Platform Beginning With COVID-19 Application
EMERYVILLE, Calif., July 27, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets and IDRI (Infectious Disease Research Institute) today announce the signing of a binding term sheet for a planned COVID-19 RNA (ribonucleic acid) vaccine technology program. The program combines IDRI's expertise in combating infectious diseases with Amyris' fermentation platform technology, with the goal to create semi-synthetic squalene-based adjuvants at scale. IDRI's RNA vaccine platform is expected to offer significant differentiated
Jul 23, 2020 08:30 am ET
Amyris To Host Second Quarter 2020 Financial Results Conference Call On August 6
EMERYVILLE, Calif., July 23, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that the company will host a conference call for investors and analysts on Thursday, August 6, 2020 at 6:00 a.m. PT (9:00 a.m. ET) to discuss its second quarter 2020 results.
Jul 20, 2020 01:29 pm ET
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Amyris, Inc. (“Amyris” or “the Company”) (NASDAQ:
Jul 16, 2020 06:31 pm ET
INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Amyris, Inc. and Encourages Investors With Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Amyris, Inc. (“Amyris” or “the Company”) (NASDAQ:
Jul 15, 2020 08:30 am ET
Amyris Launches Plant-derived Sustainable Silica for Clean Beauty Applications
EMERYVILLE, Calif., July 15, 2020 /PRNewswire/ -- Aprinnova, Inc., an Amyris, Inc. (Nasdaq: AMRS) joint venture, the leading supplier of high performance, clean beauty ingredients is commercializing a plant-derived silica made from sugarcane ashes. Silica is used widely in personal care and cosmetics. It is traditionally sourced from non-renewable sand dredging, which requires significant energy consumption and emits large amounts of C02. The new ingredient branded Biosilica™ can be used in foundations, creams, lotions and other applications as a sustainable and better performing alternative
Jun 30, 2020 08:30 am ET
Biossance Announces Clean Academy Impact Award and Partnership With Oceana
EMERYVILLE, Calif., June 30, 2020 /PRNewswire/ -- Biossance, a pioneering clean skincare brand from Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, is pleased to announce The Clean Academy by Biossance Impact Award™ to discover and foster the growth of future sustainability and environmental leaders. The program officially launched on June 29 via a digital fireside chat with Create & Cultivate, featuring Biossance President Catherine Gore, Futur
Jun 22, 2020 08:30 am ET
Amyris Partners With AB Mauri North America To Reduce Sugar In Baking Products Using PURECANE™ Sweetener
The exclusive multi-year agreement is expected to transform the industrial baking sector in the US, Mexico and Canada markets
Jun 22, 2020 08:30 am ET
Amyris Partners With AB Mauri North America To Reduce Sugar In Baking Products Using PURECANE™ Sweetener
The exclusive multi-year agreement is expected to transform the industrial baking sector in the US, Mexico and Canada markets
Jun 10, 2020 08:30 am ET
Amyris Announces Closing Of $200 Million Private Placement
EMERYVILLE, Calif., June 10, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the closing of its previously announced private investment in public equity (PIPE) in the Company.
Jun 04, 2020 09:31 am ET
Thinking about buying stock in Dolphin Entertainment, Mereo BioPharma, Amyris Inc, JetBlue Airways, or FuelCell Energy?
NEW YORK, June 4, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DLPN, MREO, AMRS, JBLU, and FCEL.
Jun 04, 2020 08:58 am ET
Amyris Raises $200 Million From Private Placement
EMERYVILLE, Calif., June 4, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it has successfully executed a binding funding agreement with leading institutional investors to raise $200 million at $3.00 per common share through a private investment in public equity (PIPE) in the Company. The offering includes 49% of common stock and 51% of preferred stock, convertible into common stock following stockholder ap
May 21, 2020 09:18 am ET
Amyris Launches Safe Alternative To Talc-Based Baby Powder
EMERYVILLE, Calif., May 21, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the launch of "Baby Cream to Powder" under its Pipette™ baby brand giving caring parents more choice and keeping babies safe.
May 15, 2020 08:30 am ET
Amyris Changes its 2020 Annual Meeting of Stockholders to Virtual Format
EMERYVILLE, Calif., May 15, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq:AMRS), a leading synthetic biotechnology company with leadership in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that, due to public health and safety concerns related to the COVID-19 pandemic, recommendations and orders from federal, state and local authorities, and to support the health and well-being of its stockholders, employees, and others, it will host its 2020 Annual Meeting of Stockholders (the "Annual Meeting") as a virtual-
May 14, 2020 08:30 am ET
Amyris Receives GRAS Validation by Medical Expert Panel for its New Health and Nutrition Ingredient
EMERYVILLE, Calif., May 14, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq:AMRS), a leading synthetic biotechnology company with leadership in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, announces that its first health and nutrition ingredient received a validation by a unanimous Panel of Medical Experts as Generally Recognized As Safe ("GRAS"). Following this successful validation, Amyris will submit an application for FDA GRAS approval of this ingredient (currently not being named due to partner's requirements), which ha
May 08, 2020 08:30 am ET
Amyris, Inc. Reports First Quarter 2020 Results
EMERYVILLE, Calif., May 8, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced financial results for its first quarter ended March 31, 2020.
May 07, 2020 08:30 am ET
Amyris to Participate in the Oppenheimer 5th Annual Emerging Growth Conference on May 12
EMERYVILLE, Calif., May 7, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq:AMRS), a leading synthetic biotechnology company with leadership in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that management will be participating in the Oppenheimer 5th Annual Emerging Growth Conference, which will take place virtually on Tuesday, May 12, 2020. President and Chief Executive Officer John Melo, and Chief Financial Officer Han Kieftenbeld will host one-on-one meetings via teleconference throughout the day.
May 04, 2020 08:30 am ET
Amyris To Host First Quarter 2020 Financial Results Conference Call On May 8
EMERYVILLE, Calif., May 4, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biology solutions provider, owner of Clean Beauty consumer brands and provider of proprietary functional ingredients, today announced that the company will host a conference call for investors and analysts on Friday, May 8, 2020 at 6:00 a.m. PT (9:00 a.m. ET) to discuss its first quarter 2020 results.
Apr 20, 2020 08:30 am ET
Amyris Receives Approval to Sell its Fermented Sugarcane Reb M in Brazil and Canada
EMERYVILLE, Calif., April 20, 2020 /PRNewswire/ -- Amyris Inc. (NASDAQ: AMRS), a global science and technology leader of pure, sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that it has received approval from both Brazilian and Canadian regulators to expand its distribution of its fermented sugarcane Reb M, branded as Purecane™ zero calorie sweetener in the US to both of these countries.
Apr 13, 2020 07:30 am ET
Amyris Experiences Very Strong Sales Start with Pipette Hand Sanitizer for the Whole Family
EMERYVILLE, Calif., April 13, 2020 /PRNewswire/ -- Amyris Inc. (NASDAQ: AMRS), a global science and technology leader of pure, sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced the full market launch and sales of its Pipette branded hand sanitizer as of April 9th. Pipette, Amyris' clean baby skincare brand, offers the new plant derived hand sanitizer to consumers on Pipettebaby.com in 8oz and soon 32oz and 2oz sizes.
Mar 31, 2020 08:30 am ET
Amyris Scales Up in Response to High Need for Its Hand Sanitizer and Wipe Products
EMERYVILLE, Calif., March 31, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq:AMRS), a global science and technology leader of pure, sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that initial production of its hand sanitizer has started with Allure Labs as its contract manufacturing and packaging partner. Amyris has also successfully replenished its popular baby wipes that have been out of stock in most channels as fast as they restock.
Mar 26, 2020 08:30 am ET
Amyris Launches Leading Hand Sanitizer and Receives Initial Positive Result for Vaccine Adjuvant
EMERYVILLE, Calif., March 26, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq:AMRS), a global science and technology leader of pure, sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that it is launching a hand sanitizer to help address the high demand triggered by COVID-19. Additionally, the company has completed initial testing of a leading vaccine adjuvant.
Mar 16, 2020 08:05 am ET
Amyris Provides Business Update
EMERYVILLE, Calif., March 16, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq:AMRS), a global science and technology leader of pure, sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced Amyris management will be holding virtual 1X1 investor meetings today with investors due to the cancellation of the 32nd Annual Roth Conference because of COVID-19.
Dec 27, 2019 07:30 am ET
Amyris Announces Successful Shipment of First Fermentation Derived Cannabinoid to LAVVAN and Provides Business Updates
EMERYVILLE, Calif., Dec. 27, 2019 /CNW/ -- Amyris, Inc. (Nasdaq: AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today reported that it has successfully shipped the first cannabinoid to its partner, LAVVAN. Amyris is also well on its way to the shipment of a second cannabinoid in the first half of 2020.
Nov 11, 2019 07:30 am ET
Amyris Executes Agreements to Resolve CVI Heights Debt
EMERYVILLE, Calif., Nov. 11, 2019 /PRNewswire/ -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that definitive agreements have been entered into providing for the purchase of its existing CVI Heights convertible note by two "accredited investors" (as defined in Rule 501 of Regulation D promulgated under the Securities Act of 1933) and subsequent exchange of such note for new unsecured convertible senior notes (the "Notes") in the amount of $66
Nov 07, 2019 03:05 pm ET
Amyris Continues to Deliver Strong Revenue Growth
EMERYVILLE, Calif., Nov. 7, 2019 /PRNewswire/ -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced preliminary unaudited financial results for the third quarter ended September 30, 2019.
Oct 24, 2019 09:01 am ET
Haeggquist & Eck, LLP Investigates Amyris Officers and Directors Regarding Restatement of Financial Results
Haeggquist & Eck, LLP, a leading shareholder rights litigation firm, is investigating whether certain directors and officers of
Oct 23, 2019 08:30 am ET
Amyris to Announce Third Quarter Financial Results on Thursday, November 7, 2019
EMERYVILLE, Calif., Oct. 23, 2019 /PRNewswire/ -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the third quarter ended September 30, 2019 after market close on Thursday, November 7, 2019.
Oct 18, 2019 04:40 pm ET
WeissLaw LLP: Amyris, Inc. is the Subject of a Legal Investigation
NEW YORK, Oct. 18, 2019 /PRNewswire/ -- WeissLaw LLP, a national class action and shareholders' rights law firm with offices in New York, Los Angeles and Atlanta, announces the investigation of Amyris, Inc. (NASDAQ: AMRS) ("AMRS," or the "Company"), its Board of Directors, and certain Company officers for, among other things, possible breaches of fiduciary duty and violations of federal securities laws.
Oct 10, 2019 08:00 am ET
Amyris Pipette Brand Successfully Launches on Amazon.com
EMERYVILLE, Calif., Oct. 10, 2019 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leader in the development and production of sustainable products for Health and Clean Beauty, today announced the successful launch of its Pipette brand on Amazon.com.
Oct 07, 2019 02:30 pm ET
Amyris Files Form 10-Qs to Achieve Compliance - Notes Receipt of Nasdaq Deficiency Notification
EMERYVILLE, Calif., Oct. 7, 2019 /PRNewswire/ -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today reported that it has filed its required Forms 10-Q for the first quarter ended March 31, 2019 and the second quarter ended June 30, 2019. The company also noted that it has received a standard notice from Nasdaq stating that, as a result of not having timely filed these quarterly reports on Form 10-Q in accordance with the required September 30 deadline, it was
Oct 03, 2019 08:30 am ET
Biossance Introduces The Clean Academy
EMERYVILLE, Calif., Oct. 3, 2019 /PRNewswire/ -- Biossance, a pioneering clean skincare brand from Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced the launch of The Clean Academy, a comprehensive educational platform positioned to become the complete clean beauty resource for consumers and industry alike. 
Oct 01, 2019 09:23 am ET
Amyris Provides Highlights of First Half 2019 Financial Results
EMERYVILLE, Calif., Oct. 1, 2019 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) today provided highlights of its business and financial results for the first half of 2019 ended June 30, 2019, which it will review during a conference call after market close on Wednesday, October 2, 2019. The company also noted that it is has filed its 2018 Form 10-K and expects to file its Form 10-Qs for the first and second quarters of 2019 before the conference call on Wednesday. As a result of completing these filings, the company believes that it will have filed all of its delinquent SEC filings and be back
Sep 27, 2019 08:30 am ET
Amyris to Host First-Half 2019 Financial Results Teleconference on Wednesday, October 2, 2019
EMERYVILLE, Calif., Sept. 27, 2019 /PRNewswire/ -- Amyris, Inc. (Nasdaq:AMRS) today announced that it will review its financial results for the first half of 2019 ended June 30, 2019 after market close on Wednesday, October 2, 2019. The company believes that it remains on track to file its required Securities and Exchange Commission (SEC) filings by Monday, September 30.
Sep 26, 2019 09:47 am ET
Scott+Scott Attorneys at Law LLP Continues to Investigate Amyris, Inc.’s Directors and Officers for Breach of Fiduciary Duty – AMRS
Scott+Scott is investigating whether Amyris and its directors and officers made, or allowed Amyris to make, false and/or misleading statements to the investing public.
Sep 20, 2019 08:49 am ET
Amyris to Present at B. Riley FBR Annual Consumer & Media Conference on October 3, 2019
EMERYVILLE, Calif., Sept. 20, 2019 /PRNewswire/ -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that management will be presenting at the B. Riley FBR Annual Consumer & Media Conference to be held October 3, 2019, at the Sofitel New York Hotel in New York City. 
Sep 16, 2019 08:30 am ET
Clean Beauty Leader Biossance Enters the Australian and New Zealand Markets
EMERYVILLE, Calif., Sept. 16, 2019 /PRNewswire/ -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that the future of clean beauty, Biossance™ is coming to Sephora Australia and New Zealand this month and is setting a new standard in the beauty industry's commitment to sustainable solutions.  
Sep 12, 2019 03:23 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amyris, Inc. - AMRS
Pomerantz LLP is investigating claims on behalf of investors of  Amyris, Inc.  (“Amyris” or the “Company”) (NASDAQ: AMRS).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The...
Sep 09, 2019 02:35 pm ET
Scott+Scott Attorneys at Law LLP Continues Investigation into Amyris, Inc.'s Directors and Officers for Breach of Fiduciary Duty - (NASDAQ: AMRS)
NEW YORK, Sept. 9, 2019 /PRNewswire/ -- Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national securities and consumer rights litigation firm, continues to investigate whether certain directors and officers of Amyris, Inc. ("Amyris" or the "Company") (NASDAQ: AMRS) breached their fiduciary duties to the Company and its shareholders.  If you are an Amyris shareholder, you are encouraged to contact attorney Joe Pettigrew toll-free at (844) 818-6982 or at [email protected].
Sep 05, 2019 04:42 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amyris, Inc. - AMRS
Pomerantz LLP is investigating claims on behalf of investors of  Amyris, Inc.  (“Amyris” or the “Company”) (NASDAQ: AMRS).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The...
Sep 04, 2019 08:30 am ET
Amyris Launches Pipette, a Clean Baby Care Brand Delivering a Critical Need for a Growing Market
EMERYVILLE, Calif., Sept. 4, 2019 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leader in the development and production of sustainable ingredients for the Flavors & Fragrances, Health & Wellness and Clean Beauty markets, announces the official launch of Pipette today.
Aug 30, 2019 08:30 am ET
Amyris to Present at H.C. Wainwright 21st Annual Global Investment Conference on September 9, 2019
EMERYVILLE, Calif., Aug. 30, 2019 /PRNewswire/ -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that management will be presenting at the H.C. Wainwright 21st Annual Global Investment Conference to be held September 8-10, 2019, at the Lotte New York Palace Hotel in New York City. 
Aug 28, 2019 10:00 am ET
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amyris, Inc. (AMRS)
NEW YORK, Aug. 28, 2019 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Amyris, Inc. ("Amyris" or "the Company") (NASDAQ: AMRS). Investors who purchased Amyris stock are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/amrs.    
Aug 26, 2019 05:35 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amyris, Inc. - AMRS
Pomerantz LLP is investigating claims on behalf of investors of Amyris, Inc.  (“Amyris” or the “Company”) (NASDAQ: AMRS).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The...
Aug 22, 2019 04:44 pm ET
Amyris Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q
EMERYVILLE, Calif., Aug. 22, 2019 /PRNewswire/ -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today reported that it has received a standard notice from Nasdaq stating that, as a result of not having timely filed its quarterly report on Form 10-Q for the quarter ended June 30, 2019, and because it remains delinquent in filing its annual report on Form 10-K for the year ended December 31, 2018 and its quarterly report on Form 10-Q for the quarter ended March
Aug 22, 2019 11:41 am ET
Scott+Scott Attorneys at Law LLP Continues Investigation into Amyris, Inc.’s Directors and Officers for Breach of Fiduciary Duty – (NASDAQ: AMRS)
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a national securities and consumer rights litigation firm, continues to investigate whether certain directors and officers of Amyris, Inc. (“Amyris” or the “Company”) (NASDAQ: AMRS) breached their fiduciary duties to the Company and its shareholders. If you are an Am
Aug 08, 2019 09:00 am ET
LAVVAN Appoints Neil Closner as Chief Executive Officer
LAVVAN Inc. (“LAVVAN”) today announced that Neil Closner, formerly of MedReleaf Corp. ("MedReleaf"), has been appointed its new Chief Executive Officer. Joining Closner are several key members of MedReleaf’s former leadership team who were responsible for its groundbreaking achievements and success. Former LAVVAN CEO, Etan Bendheim, will become President of the company.
Jul 26, 2019 08:30 am ET
Amyris to Host Business Update Teleconference and Webcast on Monday, August 5, 2019
EMERYVILLE, Calif., July 26, 2019 /PRNewswire/ -- Amyris, Inc. (Nasdaq:AMRS) will host a business update teleconference and webcast on Monday, August 5, 2019 prior to presenting at the Jefferies Global Industrials Conference in New York on August 6, following which the company plans to participate in investor meetings in New York and Boston through August 8.
Jul 19, 2019 08:30 am ET
ADL Bionatur Solutions and Amyris Expand Contract to 2020
LEÓN, Spain and EMERYVILLE, Calif., July 19, 2019 /PRNewswire/ -- ADL Bionatur Solutions (MAB: ADL), a company specialized in research and development of sustainable health and beauty products, services and industrial fermentation production, announces today the expansion of its existing production agreement with Amyris, Inc. (Nasdaq:AMRS). Amyris is a leader in the development and production of pure, sustainable, fermentation-derived ingredients for the Health & Clean Beauty markets.
Jul 12, 2019 08:56 am ET
Amyris to Participate in and Provide Business Update at Jefferies 2019 Global Industrials Conference
EMERYVILLE, Calif., July 12, 2019 /PRNewswire/ -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that it plans to participate in the following upcoming investor conference in August 2019.
Jun 27, 2019 09:30 pm ET
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Inogen, Health Insurance Innovations, Amyris and Nutanix and Encourages Investors to Contact the Firm
Bragar Eagel & Squire is investigating certain officers and directors of Inogen, Inc., Health Insurance Innovations, Inc., Amyris, Inc., and Nutanix, Inc. More information about each potential case can be found at the link provided. Inogen,...
Jun 03, 2019 03:00 pm ET
AMRS & CRCM - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Deadline
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Jun 03, 2019 10:49 am ET
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Amyris, Inc. (“Amyris” or “the Company”) (NASDAQ: AMRS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of...
Jun 02, 2019 11:42 pm ET
AMYRIS 24 HOUR DEADLINE ALERT: APPROXIMATELY 24 HOURS REMAIN; FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Actio
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until June 3, 2019 to file lead plaintiff applications in a...
May 31, 2019 10:50 pm ET
AMYRIS 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Actio
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until June 3, 2019 to file lead plaintiff applications in a securities class action lawsuit against Amyris, Inc. (NasdaqGS: AMRS). Investor losses must relate to purchases of the Company’s securities between March 15, 2018 and March 19, 2019. This action is pending in the United States District Court for the Northern District of Cali
May 31, 2019 04:02 pm ET
Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amyris, Inc.
Law Offices of Howard G. Smith reminds investors of the upcoming June 3, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Amyris, Inc.  (“Amyris” or the “Company”) (NASDAQ: AMRS)...
May 30, 2019 06:48 pm ET
KESSLER TOPAZ MELTZER & CHECK, LLP:  Final Deadline Reminder for AMYRIS, INC. Investors – AMRS
The law firm of Kessler Topaz Meltzer & Check, LLP reminds Amyris, Inc. (Nasdaq:  AMRS) (“Amyris”) investors that a securities fraud class action lawsuit has been filed on behalf of those who purchased or otherwise acquired Amyris securities...
May 30, 2019 03:05 pm ET
AMYRIS MONDAY DEADLINE: Rosen, a Top Ranked Law Firm, Reminds Investors of Amyris, Inc. of Important June 3rd Deadline in Securities Class Action – AMRS
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Amyris, Inc. (NASDAQ: AMRS) from March 15, 2018 and March 19, 2019, inclusive (the “Class Period”) of the important June 3, 2019 lead plaintiff deadline in...
May 30, 2019 03:00 pm ET
T, AMRS & CRCM - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Deadline
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
May 29, 2019 10:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Amyris, Flex, comScore, and Mueller Water and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Amyris, Inc., Flex Ltd., comScore, Inc., and Mueller Water Products, Inc.  Stockholders have until the deadlines listed below...
May 29, 2019 03:37 pm ET
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amyris, Inc.
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming June 3, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of Amyris, Inc. (“Amyris” or the “Company”) (NASDAQ: AMRS) investors who purchased...
May 28, 2019 07:04 pm ET
INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Amyris, Inc.
The law firm of Kessler Topaz Meltzer & Check, LLP reminds Amyris, Inc. (Nasdaq: AMRS) (“Amyris”) investors that a securities fraud class action lawsuit has been filed on behalf of those who purchased or otherwise acquired Amyris securities between March 15, 2018 and March 19, 2019, inclusive (the “Class Period”).
May 27, 2019 10:58 am ET
A Securities Class Action Has Been Filed Against Amyris; Block & Leviton LLP Encourages Shareholders to Contact the Firm
Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, informs investors that there has been a class action lawsuit filed against Amyris, Inc. (“Amyris” or the “Company”) (NASDAQ: AMRS) and certain...
May 27, 2019 09:15 am ET
7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Amyris, Inc. (“Amyris” or “the Company”) (NASDAQ: AMRS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of...
May 26, 2019 09:00 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amyris, Inc. – AMRS
Pomerantz LLP is investigating claims on behalf of investors of Amyris, Inc. (“Amyris” or the “Company”) (NASDAQ: AMRS).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The...
May 24, 2019 10:50 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS AMRS, BV, FLEX, REV of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: Amyris, Inc. (AMRS) Class Period: 3/15/2018 -...
May 24, 2019 08:30 am ET
Amyris Appoints Two New Board Members with Significant Experience in Building High Growth Product and Consumer Companies
Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced the appointment of two new board members, Jim McCann,...
May 23, 2019 08:30 am ET
Amyris Teams Up with Model and Businesswoman Rosie Huntington-Whiteley as Brand Partner for its Pipette Baby Brand
Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that Rosie Huntington-Whiteley, the British supermodel,...
May 22, 2019 10:34 am ET
AMRS DEADLINE: Pawar Law Group Reminds Investors of June 3 Deadline In Securities Class Action Lawsuit Against Amyris, Inc. – AMRS
Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Amyris, Inc. (NASDAQ: AMRS) from March 15, 2018 and March 19, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover...
May 21, 2019 06:17 pm ET
Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Amyris, Inc. Investors
The law firm of Kessler Topaz Meltzer & Check, LLP reminds Amyris, Inc. (Nasdaq:  AMRS) (“Amyris”) investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of California...
May 21, 2019 02:00 pm ET
Amyris to Present at B. Riley FBR 20th Annual Institutional Investor Conference on Thursday, May 23, 2019
Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that management will be presenting at the B. Riley FBR 20th...
May 21, 2019 01:23 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amyris, Inc. – AMRS
Pomerantz LLP is investigating claims on behalf of investors of Amyris, Inc. (“Amyris” or the “Company”) (NASDAQ: AMRS). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The...
May 21, 2019 08:30 am ET
Amyris Announces the Execution of Strategic Supply Agreements with Raízen, the Largest Sugar Producer in the World
Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced the execution of strategic supply agreements with Raízen for...
May 20, 2019 05:00 pm ET
Amyris Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q
Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today reported that it has received a standard notice from Nasdaq stating...
May 20, 2019 04:11 pm ET
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Amyris, Inc. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Amyris, Inc. (“Amyris” or the “Company”) (NASDAQ:AMRS) of the June 3, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has...
May 20, 2019 03:00 pm ET
SHAREHOLDER ALERT - Amyris, Inc. (AMRS)  Bronstein, Gewirtz & Grossman, LLC Announces Class Action and Lead Plaintiff Deadline: June 3, 2019
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Amyris, Inc. (“Amyris” or the “Company”) (NASDAQ: AMRS) and certain of its officers, on behalf of shareholders who...
May 20, 2019 09:15 am ET
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Amyris, Inc. (“Amyris” or “the Company”) (NASDAQ: AMRS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of...
May 20, 2019 08:30 am ET
Amyris Announces Receipt of $10 Million Payment from LAVVAN for Delivering on First Major CBD Milestone
Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today reported that it has received from its cannabinoid partner, LAVVAN, a...
May 17, 2019 10:50 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS AMRS, BV, FLEX, REV of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: Amyris, Inc. (AMRS) Class Period: 3/15/2018 -...
May 16, 2019 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Amyris, Flex, comScore, and Mueller Water and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Amyris, Inc., Flex Ltd., comScore, Inc., and Mueller Water Products, Inc. Stockholders have until the deadlines listed below...
May 16, 2019 08:57 pm ET
AMRS NOTICE:  Zhang Investor Law Reminds Investors of June 3 Deadline in Securities Class Action Lawsuit Against Amyris, Inc. – AMRS
Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of Amyris, Inc. (NASDAQ: AMRS) from March 15, 2018 and March 19, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover...
May 16, 2019 08:32 pm ET
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amyris, Inc.
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming June 3, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of Amyris, Inc. (“Amyris” or the “Company”) (NASDAQ: AMRS) investors who purchased...
May 15, 2019 04:00 pm ET
Amyris Retires May 2019 Convertible Note Debt
Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that it has retired its 6.5% convertible notes due May 2019....

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.